FZD2 and pheochromocytoma-paraganglioma: No significant differences in FZD2 expression were observed in UCEC, cervical squamous cell carcinoma (CESC), THCA, READ, acute lymphoblastic leukemia (ALL), or pheochromocytoma and paraganglioma (PCPG) (Figure 2B).